Skip to main content

Table 2 Response to therapy and organ assessment

From: The combination of methotrexate and cytosine arabinoside in newly diagnosed adult Langerhans cell histiocytosis: a prospective phase II interventional clinical trial

Cycles of chemotherapy 6
Patients available for survival analysis 36
Follow-up (mon) 44 (31–59)
EFS (mon) 39.5 (12–59)
Recurrence 10
Death 1 (death from disease progression)
Response (available for response evaluation) 36
 Better 36
 Complete resolution (NAD) 6
 Regressive disease 30
Organ resolution
 Bone lesions (imaging evaluation) 31
 CR 12
 PR 19
 Bone aching 18
  Complete regression 14
  Partial regression 4
 CNS lesions (imaging evaluation) 25
 CR 13
 PR 12